Huddinge, Sweden

Eva Koch

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Karo Pharma Ab. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eva Koch. Retrieved from https://idiyas.com/inventor/eva-koch-vqhzrbtj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eva Koch - Innovator in Estrogen Receptor Ligands

Introduction

Eva Koch is a prominent inventor based in Huddinge, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of estrogen receptor ligands. Her work has implications for various therapeutic applications, showcasing her expertise and dedication to innovation.

Latest Patents

Eva Koch holds a patent for compounds that serve as estrogen receptor ligands. The patent details compounds of formula (I) or pharmaceutically acceptable esters, amides, carbamates, or salts thereof. These compounds are defined in the specification and are recognized for their utility as estrogen receptor ligands.

Career Highlights

Eva Koch is associated with Karo Pharma AB, where she has been instrumental in advancing research and development in her field. Her innovative approach and commitment to scientific excellence have positioned her as a key figure in her organization.

Collaborations

Eva has collaborated with notable colleagues, including Aiping Cheng and Neeraj Garg. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Eva Koch's contributions to the field of estrogen receptor ligands exemplify her innovative spirit and dedication to advancing pharmaceutical science. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…